Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans. 2008

Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
Cancer and Vascular Biology Research Center, Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Heparanase is a heparan sulfate (HS) degrading endoglycosidase participating in extracellular matrix degradation and remodeling. Apart of its well characterized enzymatic activity, heparanase was noted to exert also enzymatic-independent functions. Non-enzymatic activities of heparanase include enhanced adhesion of tumor-derived cells and primary T-cells. Attempting to identify functional domains of heparanase that would serve as targets for drug development, we have identified heparin binding domains of heparanase. A corresponding peptide (residues Lys(158)-Asp(171), termed KKDC) was demonstrated to physically associate with heparin and HS, and to inhibit heparanase enzymatic activity. We hypothesized that the pro-adhesive properties of heparanase are mediated by its interaction with cell surface HS proteoglycans, and utilized the KKDC peptide to examine this possibility. We provide evidence that the KKDC peptide interacts with cell membrane HS, resulting in clustering of syndecan-1 and syndecan-4. We applied classical analysis of cell morphology, fluorescent and time-lapse microscopy and demonstrated that the KKDC peptide efficiently stimulates the adhesion and spreading of various cell types, mediated by PKC, Src, and the small GTPase Rac1. These results support, and further substantiate the notion that heparanase function is not limited to its enzymatic activity.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005966 Glucuronidase Endo-beta-D-Glucuronidase,Endoglucuronidase,Exo-beta-D-Glucuronidase,beta-Glucuronidase,Endo beta D Glucuronidase,Exo beta D Glucuronidase,beta Glucuronidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
October 2004, The Journal of biological chemistry,
Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
May 1992, The Journal of biological chemistry,
Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
January 1992, Advances in experimental medicine and biology,
Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
January 1999, Annual review of biochemistry,
Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
January 1987, Medical biology,
Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
January 2015, Molecular cancer,
Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
November 1999, Cellular and molecular life sciences : CMLS,
Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
August 2013, Journal of controlled release : official journal of the Controlled Release Society,
Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
May 2022, American journal of physiology. Cell physiology,
Flonia Levy-Adam, and Sari Feld, and Edith Suss-Toby, and Israel Vlodavsky, and Neta Ilan
November 2009, Cellular and molecular life sciences : CMLS,
Copied contents to your clipboard!